BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27837120)

  • 1. Recommendations for high-risk clinical target volume definition with computed tomography for three-dimensional image-guided brachytherapy in cervical cancer patients.
    Ohno T; Wakatsuki M; Toita T; Kaneyasu Y; Yoshida K; Kato S; Ii N; Tokumaru S; Ikushima H; Uno T; Noda SE; Kazumoto T; Harima Y;
    J Radiat Res; 2017 May; 58(3):341-350. PubMed ID: 27837120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer.
    Smet S; Nesvacil N; Knoth J; Sturdza A; Najjari-Jamal D; Jelinek F; Kronreif G; Pötter R; Widder J; Kirisits C; Schmid MP
    Strahlenther Onkol; 2020 Nov; 196(11):983-992. PubMed ID: 32621011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition?
    Schmid MP; Nesvacil N; Pötter R; Kronreif G; Kirisits C
    Radiother Oncol; 2016 Sep; 120(3):467-472. PubMed ID: 26921168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CT-based and MRI-based high-risk clinical target volumes in image guided-brachytherapy for cervical cancer, referencing recommendations from the Japanese Radiation Oncology Study Group (JROSG) and consensus statement guidelines from the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC ESTRO).
    Iwai Y; Nemoto MW; Horikoshi T; Kanazawa A; Kurokawa M; Saito M; Harada R; Kobayashi H; Uno T
    Jpn J Radiol; 2020 Sep; 38(9):899-905. PubMed ID: 32333219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk clinical target volume delineation in CT-guided cervical cancer brachytherapy: impact of information from FIGO stage with or without systematic inclusion of 3D documentation of clinical gynecological examination.
    Hegazy N; Pötter R; Kirisits C; Berger D; Federico M; Sturdza A; Nesvacil N
    Acta Oncol; 2013 Oct; 52(7):1345-52. PubMed ID: 23905674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of Magnetic Resonance Imaging Without or With Applicator in Place for Target Definition in Cervix Cancer Brachytherapy.
    Pötter R; Federico M; Sturdza A; Fotina I; Hegazy N; Schmid M; Kirisits C; Nesvacil N
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):588-97. PubMed ID: 26867887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prospective Comparison of Computed Tomography with Transrectal Ultrasonography Assistance and Magnetic Resonance Imaging-Based Target-Volume Definition During Image Guided Adaptive Brachytherapy for Cervical Cancers.
    Mahantshetty U; Naga Ch P; Khadanga CR; Gudi S; Chopra S; Gurram L; Jamema S; Ghadi Y; Shrivastava S
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1448-1456. PubMed ID: 30146092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
    Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
    Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer.
    Shi D; He MY; Zhao ZP; Wu N; Zhao HF; Xu ZJ; Cheng GH
    Asian Pac J Cancer Prev; 2015; 16(9):3945-9. PubMed ID: 25987066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining transrectal ultrasound and CT for image-guided adaptive brachytherapy of cervical cancer: Proof of concept.
    Nesvacil N; Schmid MP; Pötter R; Kronreif G; Kirisits C
    Brachytherapy; 2016; 15(6):839-844. PubMed ID: 27693172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-guided brachytherapy for cervical cancer: a Canadian Brachytherapy Group survey.
    Pavamani S; D'Souza DP; Portelance L; Craighead PS; Pearce AG; Traptow LL; Doll CM
    Brachytherapy; 2011; 10(5):345-51. PubMed ID: 21345744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
    Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
    Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society.
    Viswanathan AN; Erickson BA
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):104-9. PubMed ID: 19619956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical cancer using a hybrid magnetic resonance imaging/computed tomography approach: feasibility and early results.
    Beriwal S; Kannan N; Kim H; Houser C; Mogus R; Sukumvanich P; Olawaiye A; Richard S; Kelley JL; Edwards RP; Krivak TC
    Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):685-90. PubMed ID: 21908180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted MRI in image-guided adaptive brachytherapy: Tumor delineation feasibility study and comparison with GEC-ESTRO guidelines.
    Schernberg A; Balleyguier C; Dumas I; Gouy S; Escande A; Bentivegna E; Morice P; Deutsch E; Haie-Meder C; Chargari C
    Brachytherapy; 2017; 16(5):956-963. PubMed ID: 28673762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group.
    Nag S; Cardenes H; Chang S; Das IJ; Erickson B; Ibbott GS; Lowenstein J; Roll J; Thomadsen B; Varia M;
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1160-72. PubMed ID: 15519788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: Dosimetry comparisons and clinical outcome.
    Choong ES; Bownes P; Musunuru HB; Rodda S; Richardson C; Al-Qaisieh B; Swift S; Orton J; Cooper R
    Brachytherapy; 2016; 15(1):40-8. PubMed ID: 26602964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy.
    Hellebust TP; Kirisits C; Berger D; Pérez-Calatayud J; De Brabandere M; De Leeuw A; Dumas I; Hudej R; Lowe G; Wills R; Tanderup K;
    Radiother Oncol; 2010 Aug; 96(2):153-60. PubMed ID: 20663578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.